Background
Background More than half of the cardiac stress tests require pharmacologic vasodilators for induction of hyperemia to assess myocardial perfusion, but carry the potential for side effects and are contraindicated in many patients considered for testing. We evaluated the feasibility of a non-invasive and safe stress-testing paradigm using a precisely targeted partial pressure of arter-ial CO2 (PaCO2) to induce myocardial hyperemia, and compared this response to intravenous adenosine.
Methods
Dose-response studies were performed on spontaneously breathing humans (n = 18), and canines (n = 18) with and without surgically implemented coronary stenosis to determine the optimal increase in PaCO2 required to 1 Cedars Sinai Medical Center, Los Angeles, California, USA Full list of author information is available at the end of the article replicate the hyperemic response to intravenous adenosine (140 μg/kg/min). Blood-Oxygen-Level-Dependent (BOLD) CMR was used to determine the effects of hypercapnea.
Results
In humans, an increase in PaCO2 of 10 mmHg was well tolerated, and the BOLD CMR responses were similar to those due to standard adenosine (p = 0.7). In intact canines, the BOLD response to a mean increase in PaCO2 of 11 mmHg was similar to that of adenosine infusion (140 μg/kg/min, p = 0.4); the responses were also similar in the territories subtended by stenotic (p = 0.7) vessels.
Conclusions
Conclusion Targeted increases in PaCO2 of 10 mmHg is well tolerated and has a myocardial vasodilating effect similar in extent to that of adenosine. These findings support continued investigation into the feasibility of inhaled CO2 as a vasodilator for cardiac stress testing. 
